Potential applications of chitosan in veterinary medicine
- PMID: 15191793
- DOI: 10.1016/j.addr.2004.02.007
Potential applications of chitosan in veterinary medicine
Abstract
Chitosan is a partially deacetylated polymer obtained from the alkaline deacetylation of chitin which is a glucose-based unbranched polysaccharide widely distributed in nature as the principal component of exoskeletons of crustaceans and insects as well as of cell walls of some bacteria and fungi. Chitosan exhibits a variety of physicochemical and biological properties resulting in numerous applications in fields such as waste and water treatment, agriculture, fabric and textiles, cosmetics, nutritional enhancement, and food processing. In addition to its lack of toxicity and allergenicity, and its biocompatibility, biodegradability and bioactivity make it a very attractive substance for diverse applications as a biomaterial in pharmaceutical and medical fields, where it has been used for systemic and local delivery of drugs and vaccines. It also has bioactive properties in its own right. This paper reviews current veterinary applications for chitosan including wound healing, bone regeneration, analgesic and antimicrobial effects. It also discusses the potential application of chitosan to drug and vaccine delivery in veterinary species. Given the restrictions imposed by financial and animal restraint considerations, especially in farming applications, the veterinary drug delivery areas most likely to benefit from chitosan are the delivery of chemotherapeutics such as antibiotics, antiparasitics, anaesthetics, painkillers and growth promotants to mucosal epithelium for absorption for local or systemic activity, and the delivery of immunomodulatory agents to the mucosal associated lymphoid tissue for induction or modulation of local immune responses. The properties of chitosan expected to enhance these functions are discussed, and the future research directions in this field are indicated.
Similar articles
-
The promise of chitosan microspheres in drug delivery systems.Expert Opin Drug Deliv. 2007 May;4(3):263-73. doi: 10.1517/17425247.4.3.263. Expert Opin Drug Deliv. 2007. PMID: 17489653 Review.
-
Therapeutic potential of chitosan and its derivatives in regenerative medicine.J Surg Res. 2006 Jun 15;133(2):185-92. doi: 10.1016/j.jss.2005.12.013. Epub 2006 Feb 3. J Surg Res. 2006. PMID: 16458923 Review.
-
[Applications of chitosan and its derivatives in pharmaceutical industry of Chinese medicine].Zhongguo Zhong Yao Za Zhi. 2004 Apr;29(4):289-92. Zhongguo Zhong Yao Za Zhi. 2004. PMID: 15706858 Review. Chinese.
-
Chitosan and its salts for mucosal and transmucosal delivery.Expert Opin Drug Deliv. 2009 Sep;6(9):923-39. doi: 10.1517/17425240903114142. Expert Opin Drug Deliv. 2009. PMID: 19637983 Review.
-
Review paper: chitosan derivatives as promising materials for controlled drug delivery.J Biomater Appl. 2008 Jul;23(1):5-36. doi: 10.1177/0885328208091562. J Biomater Appl. 2008. PMID: 18593819 Review.
Cited by
-
Dense chitosan surgical membranes produced by a coincident compression-dehydration process.J Biomater Sci Polym Ed. 2013;24(5):621-43. doi: 10.1080/09205063.2012.701549. Epub 2012 Aug 13. J Biomater Sci Polym Ed. 2013. PMID: 23565872 Free PMC article.
-
Chitosan/Silk Fibroin Materials for Biomedical Applications-A Review.Polymers (Basel). 2022 Mar 26;14(7):1343. doi: 10.3390/polym14071343. Polymers (Basel). 2022. PMID: 35406217 Free PMC article. Review.
-
Development of Chitosan/Silver Sulfadiazine/Zeolite Composite Films for Wound Dressing.Pharmaceutics. 2019 Oct 14;11(10):535. doi: 10.3390/pharmaceutics11100535. Pharmaceutics. 2019. PMID: 31615120 Free PMC article.
-
Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo.Oncotarget. 2017 Nov 30;8(67):111318-111332. doi: 10.18632/oncotarget.22791. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340056 Free PMC article.
-
Use of hybrid chitosan membranes and human mesenchymal stem cells from the Wharton jelly of umbilical cord for promoting nerve regeneration in an axonotmesis rat model.Neural Regen Res. 2012 Oct 15;7(29):2247-58. doi: 10.3969/j.issn.1673-5374.2012.29.002. Neural Regen Res. 2012. PMID: 25538746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources